Home
Search

Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
New Strategic Vision for Biotechnology…
The Biotechnology Innovation Organization (BIO) today announced a new, strategic direction that will help guide it to achieving long-term goals while maintaining responsiveness to changing political headwinds. Announcing the new vision, mission and…
Learn more
BIO’s Dr. McMurry-Heath Applauds FDA Release of…
Dr. Michelle McMurry-Heath, the president and CEO of the Biotechnology Innovation Organization (BIO), today applauded the Food and Drug Administration (FDA) for publicly releasing new guidance related to the emergency use authorization of future…
Learn more
BIO Appoints New CFO
The Biotechnology Innovation Organization (BIO) announced today the retirement of Senior Vice President and Chief Financial Officer (CFO), Yvette White-Wiggins, after a distinguished 18-year career with the organization. White-Wiggins rose through…
Learn more
All Press Releases
  • Show All
Search
Results
USDA Secretary Headlines First-Ever BIO IMPACT Ag & Environment Digital Conference
September 9, 2020
Washington, D.C. (September 9, 2020) – U.S. Agriculture (USDA) Secretary Sonny Perdue will join leaders across the bioeconomy—in agriculture, sustainable fuels, and biobased manufacturing— for discussions on the role of biotechnology in protecting…
Biotech Leaders Outline Principles to Ensure the “Public’s Trust” in New Medical Products for Eradicating Covid-19
September 3, 2020
As America’s researchers race to develop the scientific solutions needed to eradicate Covid-19, leaders within the Biotechnology Innovation Organization (BIO) released an open letter to their biopharmaceutical colleagues that articulates key…
New CMS Reimbursement Rule “Reaffirms the Many Benefits of Transformational Therapies”
September 2, 2020
Today, the Centers for Medicare and Medicaid Services finalized this year’s inpatient prospective payment system (IPPS) rule, which includes a new diagnosis-related group (DRG) to streamline reimbursements for providers administering CAR T-cell…
EPA Rulemaking Recognizes the Importance of Innovation
September 1, 2020
Washington, D.C. (September 1, 2020) – A U.S. regulatory system that keeps pace with science will put much-needed tools into the hands of farmers, help combat climate change, and advance sustainable farming practices, according to the Biotechnology…
Inova and BIO Launch New Virtual Partnering Series
August 31, 2020
  Today, Inova Software and the Biotechnology Innovation Organization (BIO) are announcing the first international series of virtual partnering events focused on three critical therapeutic areas with great unmet need -  oncology,…
BIO: FDA Oversight of Animal Biotechnology Must Be Changed
August 19, 2020
America’s position as an innovation leader is at stake  Washington, D.C. (August 19, 2020) – The U.S. government’s system for regulating animal biotechnology – currently under the U.S. Food and Drug Administration (FDA) – is broken and is…
Ensuring Scientific Justice by Building Bridges to Minority Communities is Centerpiece of BIOEquality Agenda
August 6, 2020
New focus on justice through equity in diverse clinical trials, STEM education and expanding entrepreneurship to undeserved communities will drive nation’s largest life science advocacy organization The Biotechnology Innovation Organization (BIO)…
American Producers’ Access to Biotech Innovation Critical to Strengthening Economy and Addressing Climate Change
July 31, 2020
Today, the Biotechnology Innovation Organization (BIO) submitted its comments in response to the U.S. Department of Agriculture’s (UDSA) Solicitation of Input from Stakeholders on Agricultural Innovations, part of the Department’s Agriculture…
BIO Announces New Leadership for Food and Agriculture Section Governing Board
July 29, 2020
Washington, D.C. (July 29, 2020) – The Food and Agriculture Section of the Biotechnology Innovation Organization (BIO) is pleased to announce the election of its new Board leadership. Sylvia Wulf, CEO of AquaBounty Technologies, Inc., and Brian…
BIO’s Dr. McMurry-Heath Warns Executive Order to “Cripple Small, Innovative Companies” Working to Eradicate COVID-19
July 24, 2020
Says biopharma researchers and scientists stand ready to support real solutions that will address patient drug costs, continue lifesaving science Dr. Michelle McMurry-Heath, the president and CEO of the Biotechnology Innovation Organization (BIO),…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy. 

Sign Up Today